The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension

Jiaming Xiu1,2, Xueqin Lin1,2, Qiansheng Chen1

  • 1Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.

Insights

Elevated systemic inflammation, measured by the Aggregate Index of Systemic Inflammation (AISI), is linked to higher cardiovascular mortality risk in hypertension patients. This marker may signal a poor prognosis.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Public Health

Background:

  • Hypertension (HTN) pathophysiology involves inflammation.
  • The Aggregate Index of Systemic Inflammation (AISI) is a novel inflammatory and prognostic marker.

Purpose of the Study:

  • To investigate the association between hypertension and AISI.
  • To determine if AISI predicts cardiovascular mortality in hypertensive adults.

Main Methods:

  • Analysis of National Health and Nutrition Examination Survey (NHANES) data (1999-2018).
  • Inclusion of 23,765 participants with hypertension.
  • Assessment of cardiovascular mortality risk using survival curves and Cox regression, stratified by AISI quartiles.

Main Results:

  • High AISI levels significantly correlate with increased cardiovascular mortality in hypertensive patients.
  • The highest AISI quartile (Q4) showed a significantly higher risk of cardiovascular mortality (HR: 1.91) compared to the lowest (Q1).
  • Associations remained consistent across subgroups for age, gender, and obesity.

Conclusions:

  • Elevated AISI is significantly associated with increased cardiovascular mortality in adults with hypertension.
  • AISI may function as an early warning indicator for adverse cardiovascular outcomes in hypertensive individuals.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
35
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
23
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
27
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
57
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34